GPT and metabolic dysfunction-associated steatotic liver disease: Both serum ALT and AST levels were elevated in the NAFLD group when compared to the control, YCHT in all the 3 concentrations suppressed the ALT and AST levels that were increased by NAFLD (Fig. 4E and F).